Boehringer Ingelheim develops potential treatment for severe COVID-19 complications

The FINANCIAL -- Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of…

2 years ago

CDC Halloween guidelines warn about high risk activities

The FINANCIAL -- As many people in the United States begin to plan for fall and winter holiday celebrations, CDC…

2 years ago